Sign in

Susie Shapiro

@susie-shapiro.bsky.social
160 followers 150 following 4 posts

Haematology Consultant (Haemostasis and Thrombosis), Oxford. Views my own.

PostsRepliesMedia
Susie Shapiro @susie-shapiro.bsky.social · 31/07/2025
Link to pre-proof of our review on frailty and frailty syndromes in people with haemophilia doi.org/10.1016/j.jt... Hope to raise awareness to improve screening and current clinical pathways. Much more work needed including for women and for other bleeding disorders!
doi.org
Redirecting
000
Reposted by Susie Shapiro
International Society on Thrombosis and Haemostasis @isth.org · 16/04/2025
This #WorldHemophiliaDay, we’re spotlighting the overlooked history of women and hemophilia. Experts Paula James and Megan Chaigneau join the ISTH Pulse Podcast to share insights from their powerful narrative review in @jthjournal.bsky.social 🎧Listen: bit.ly/3Ept29w #WHD2025
065
Reposted by Susie Shapiro
International Society on Thrombosis and Haemostasis @isth.org · 17/04/2025
🎉 Happy #WorldHemophiliaDay! This year’s theme, “Access for all: Women and girls bleed too,” is a call to action and a reminder that equity in care starts with awareness. Here’s to building a more inclusive future, together. 💪 #WHD2025 #WeBleedToo #ISTH2025
031
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 31/03/2025
Comprehensive review of gene therapy in #hemophilia accepted for publication by Molecular Therapy. The pre-proof is on line at tinyurl.com/3sb4nuex
043
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 03/04/2025
Important paper: In patients with cancer and venous thrombosis, extended anticoagulation with low dose Apixaban is as good as full dose Apixaban in preventing thrombosis recurrence and is associated with less bleeding. tinyurl.com/yyfuan35
0133
Reposted by Susie Shapiro
Nature @nature.com · 06/03/2025
In an unprecedented move, the US National Institutes of Health has begun mass terminations of research grants that fund active scientific projects because they no longer meet “agency priorities”. go.nature.com/4bpG2It
go.nature.com
Exclusive: NIH to terminate hundreds of active research grants
Studies that touch on LGBT+ health, gender identity and DEI in the biomedical workforce could be terminated, according to documents obtained by Nature.
20342276
Reposted by Susie Shapiro
Dr Fraser Mcrae @fibrin-fraser.bsky.social · 29/01/2025
Great to share our new paper in @jthjournal.bsky.social - Fibrin film on clots is increased by hematocrit but reduced by inflammation: implications for platelets and fibrinolysis www.jthjournal.org/article/S153... @universityofleeds.bsky.social #fibrinogen #thrombosis #hemostasis #inflammation
jthjournal.org
Fibrin film on clots is increased by hematocrit but reduced by inflammation: implications for platelets and fibrinolysis
Blood clot formation, triggered by vascular injury, is crucial for hemostasis and thrombosis. Blood clots are composed mainly of fibrin fibers, platelets, and red blood cells (RBCs). Recent studies sh...
065
Reposted by Susie Shapiro
Dan Lasserson @danlasserson.bsky.social · 10/01/2025
Should patients seen in #SDEC #AmbulatoryCare receive #VTE prophylaxis? Our data #WarwickMedSchool @susie-shapiro.bsky.social show VTE rate in SDEC as high as hospitalised patients. Ability to ambulate does NOT equal reduced VTE risk. @ukhahsoc.bsky.social www.sciencedirect.com/science/arti...
authors.elsevier.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
1114
Susie Shapiro @susie-shapiro.bsky.social · 10/01/2025
We report 0.9% VTE within 90 days of hospital led acute ambulatory care attendance; similar to traditional medical inpatient care without thromprophylaxis. Further VTE research needed in this rapidly expanding area of medicine#VTE#SDEC @danlasserson.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Same-day emergency care: a retrospective observational study of the incidence and predictors of venous thromboembolism following hospital-based acute ambulatory medical care
Same-day emergency care (SDEC) is an expanding area of hospital acute medical care. It aims to minimize delays and manage medical emergency patients w…
154
Reposted by Susie Shapiro
Richard Buka @richardbuka.bsky.social · 07/01/2025
Pleased to share this perspective on andexanet alfa, now published in @rpth.bsky.social #openaccess🔓 rpthjournal.org/article/S2475-… I cover blinding, surrogate endpoints, clinical outcomes and thrombosis. A brief 🧵
121
Reposted by Susie Shapiro
Thomas Reiser @tomreiser.bsky.social · 09/01/2025
This is your chance to shape the field of #thrombosis and #hemostasis. Apply for editorial positions at @isth-official.bsky.social journals @RPTH.bsky.social - Assoc. Editor (2x) @JTHjournal.bsky.social - Early Career Assoc. Editor (1x) Deadline is Jan 30! Apply here 👇 buff.ly/3BRloDM
0116
Reposted by Susie Shapiro
RPTH @rpth.bsky.social · 15/12/2024
🩸 Nonneutralizing antibodies (NNAs) in moderate #hemophilia A & B were found in 13% of Nordic patients, linked to >150 exposure days and worse joint outcomes (higher joint health scores, more surgeries). Further research is key to understanding these impacts! @ragnhijm buff.ly/3OWH58e
001
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 11/12/2024
Until now, (non-approved) emicizumab use in acquired hemophilia A was all about reduction in bleeds and improved convenience for patients and medical staff. Now the German group showed at #ASH2024 that it results in improved survival. Not randomised but impressive.
0101
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 11/12/2024
Systematic review and meta-analysis of all the AAV gene therapy trials in #hemophilia A and B. Remarkably, 395 patients have had gene therapy for hemophilia during the clinical trials already. tinyurl.com/47vrua3v
1152
Reposted by Susie Shapiro
Ben Samelson-Jones, MD, PhD @samelsonjones.bsky.social · 07/12/2024
#Ash24 #hemesky Very large datasets suggest factor 12 haploinsufficiency substantially reduce venous #thrombosis. Suggest intravascular pathological clot formation is molecularly different than extra vascular hemostatic clot formation?
162
Reposted by Susie Shapiro
Mary Cushman 🫀🧠🩸 @marycushmanmd.bsky.social · 09/12/2024
Fascinating study from administrative data showing 20% lower risk of #VTE with GLP-1 receptor agonist use in diabetes in a large population sample. Association was similar even in people with normal BMI. #ASH24
0193
Reposted by Susie Shapiro
Haemnet @haemnet.bsky.social · 09/12/2024
90% of women with #vonWillebrandDisease in our pilot study said their periods are heavy, impacting physical and general daily activities. We want to help change this. Can you help us? If you live with von Willebrand’s, find out more about our survey here: loom.ly/yIk8Rwg #HemeSky #MedSky
021
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 04/12/2024
Paper in this week's NEJM shows that in patients with atrial fibrillation and stable coronary artery disease, edoxaban monotherapy is superior to the combination of edoxaban plus an antiplatelet drug. Major difference was in bleeding rather than reduction in ischaemic events.
11811
Susie Shapiro @susie-shapiro.bsky.social · 04/12/2024
Really proud of our physio Steph! Thank you to UK Haemophilia Society, Ben and others for this lovely recognition of her care and support! @ouhospitals.bsky.social www.ouh.nhs.uk/news/article...
ouh.nhs.uk
Award-winning physiotherapist celebrated for ‘outstanding’ care - Oxford University Hospitals
Award-winning physiotherapist celebrated for ‘outstanding’ care
021
Reposted by Susie Shapiro
Richard Buka @richardbuka.bsky.social · 25/11/2024
Tons of NEW DATA about andexanet, presented as part of FDA hearing last week. If you couldn’t make it through the short 6h meeting, GOOD NEWS, I’ve watched it and highlighted the important points. A🧵
195
Reposted by Susie Shapiro
Thomas Reiser @tomreiser.bsky.social · 26/11/2024
⌛The countdown is on! The ISTH 2025 abstract submission portal opens Nov 29. Join us for #ISTH2025 in Washington DC & plan to showcase your research on the global stage. 🗓️Abstract submission deadline is Jan. 15! 💡http://isth2025.org/abstracts #HemeSky
02111
Reposted by Susie Shapiro
ProfMakris @profmakris.bsky.social · 26/11/2024
The World Federation of #Hemophilia 2023 Annual Global Survey was published today. These are the best international data on inherited bleeding disorders. Europe and the Americas have 28% of the world population and use 79% of the world's FVIII concentrate. tinyurl.com/4muevre6
073
Reposted by Susie Shapiro
Prof Beverley Hunt OBE @bhwords.bsky.social · 21/11/2024
Wow! PETS has closed after recruiting over 11,000 because the research Q as to the benefit of stockings in low risk surgical pts has been answered. We wont know the answer until completed analysis & then publication in 2025 The largest ever trial on stocking!
072
Susie Shapiro @susie-shapiro.bsky.social · 20/11/2024
Really exciting to have gene therapy for haemophilia B as an option in the UK. It needed us to establish new models of care to ensure access and safety. UK guidance for implementation of gene therapy just published: doi.org/10.1111/hae....
doi.org
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults
Introduction 2022 was a landmark year with two adeno-associated viral vectors (AAVs) receiving conditional marketing authorization from EMA for the treatment of persons with severe haemophilia A and.....
041